UPDF AI

Cancer incidence and mortality in China, 2022

B. Han,R. Zheng,6 Autores,Jie He

2024 · DOI: 10.1016/j.jncc.2024.01.006
Journal of the National Cancer Center · 1,525 Citações

TLDR

Sustained implementation of prevention and control measures has resulted in significant reductions in the incidence and mortality rates of certain historically high incidence cancers, such as esophageal, stomach and liver cancers in China, with a cancer profile that reflects the coexistence of developed and developing regions.